These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Calcium antagonism: aldosterone and vascular responses to catecholamines and angiotensin II in man. Elliott HL J Hypertens Suppl; 1993 Dec; 11(6):S13-6. PubMed ID: 8169376 [TBL] [Abstract][Full Text] [Related]
5. The clinical importance of cardioselectivity and lipophilicity in beta blockers. Cruickshank JM Am Heart J; 1980 Aug; 100(2):160-78. PubMed ID: 6105819 [No Abstract] [Full Text] [Related]
6. Aliskiren, the future of renin-angiotensin system blockade? Uresin Y; Mehtar Bozkurt M; Sabirli S; Ozunal ZG Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):835-49. PubMed ID: 17867914 [TBL] [Abstract][Full Text] [Related]
7. The sympathoadrenal system in the maintenance of elevated arterial pressure. Izzo JL J Cardiovasc Pharmacol; 1984; 6 Suppl 3():S514-21. PubMed ID: 6208421 [No Abstract] [Full Text] [Related]
8. [Pharmacology and clinical pharmacokinetics of nadolol]. Lazowski J; Wegrzyn B; Lypka A Pol Tyg Lek; 1981 Sep; 36(39):1521-4. PubMed ID: 6121320 [No Abstract] [Full Text] [Related]
13. [Pharmacological correction of hyperactivity of renin-angiotensin-aldosterone system]. Antelava NA; Kezeli TD; Nikuradze NS; Pachkoriia KZ; Shakulashvili GG Georgian Med News; 2005 Dec; (129):92-8. PubMed ID: 16444043 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacological control of the catacholamine effect on heart and circulation]. Imhof P Vasa; 1978; 7(2):108-13. PubMed ID: 26144 [No Abstract] [Full Text] [Related]
15. Cardiac consequences of aldosterone excess in human hypertension. Rossi GP Am J Hypertens; 2006 Jan; 19(1):10-2. PubMed ID: 16461183 [No Abstract] [Full Text] [Related]
16. [Cardiovascular pharmacology (IV). The current validity of "old" drugs: beta-blockers]. Permanyer Miralda G; Sanz Girgas E Rev Esp Cardiol; 1994 Sep; 47(9):616-25. PubMed ID: 7973029 [No Abstract] [Full Text] [Related]
17. The sympathoadrenal system mediates the blood pressure and cardiac effects of human coagulation factor XII-related "new pressor protein". Mavrogiannis L; Trambakoulos DM; Boomsma F; Osmond DH Can J Cardiol; 2002 Oct; 18(10):1077-86. PubMed ID: 12420043 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin receptor blockers: current status and future prospects. Kumar S; Ram CV Indian Heart J; 2007; 59(6):443-53. PubMed ID: 19151457 [No Abstract] [Full Text] [Related]
19. Involvement of the vascular renin-angiotensin system in beta adrenergic receptor-mediated facilitation of vascular neurotransmission in spontaneously hypertensive rats. Kawasaki H; Cline WH; Su C J Pharmacol Exp Ther; 1984 Oct; 231(1):23-32. PubMed ID: 6149303 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise. Stubenitsky R; van der Weerd RW; Haitsma DB; Verdouw PD; Duncker DJ Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]